Transmission-blocking activities of quinine, primaquine, and artesunate
about
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmissionPrimaquine or other 8-aminoquinoline for reducing P. falciparum transmissionPrimaquine for reducing Plasmodium falciparum transmissionThe role of early detection and treatment in malaria eliminationActivity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence "transmission blocking" assayTherapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest EthiopiaTransmission blocking activity of a standardized neem (Azadirachta indica) seed extract on the rodent malaria parasite Plasmodium berghei in its vector Anopheles stephensiSuppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replicationRevisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.The impact of human reservoir of malaria at a community-level on individual malaria occurrence in a low malaria transmission setting along the Thai-Myanmar border.Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SPEpidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationWhole-cell in vitro screening for gametocytocidal compounds.Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivaxAssessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malariaDose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malariaDifferential CYP 2D6 metabolism alters primaquine pharmacokinetics.Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blueImaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against Plasmodium falciparum female gamete formation.Population-wide malaria testing and treatment with rapid diagnostic tests and artemether-lumefantrine in southern Zambia: a community randomized step-wedge control trial design.Plasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compounds.Use of Plasmodium falciparum culture-adapted field isolates for in vitro exflagellation-blocking assayThe spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector.An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in CambodiaUltrastructural and real-time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs.Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali.HIV treatments have malaria gametocyte killing and transmission blocking activity.Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populationsCytostatic versus cytocidal profiling of quinoline drug combinations via modified fixed-ratio isobologram analysis.Imidazoquines as antimalarial and antipneumocystis agents.The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial.Plasmodium cell biology should inform strategies used in the development of antimalarial transmission-blocking drugs.Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity.Blocking Plasmodium falciparum Malaria Transmission with Drugs: The Gametocytocidal and Sporontocidal Properties of Current and Prospective Antimalarials.Activities of 11-Azaartemisinin and N-Sulfonyl Derivatives against Asexual and Transmissible Malaria Parasites.Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
P2860
Q24188070-CDA68FE7-3907-4347-A5E2-A8D84C7C1D27Q24193716-ACE04183-792E-42A6-AEF6-4A10AF24EB20Q24200471-66CF7B56-F66A-4123-BDE4-C941630EC5D0Q26740068-04122611-C864-4D39-BE27-DFC8AD7D9BE2Q28482292-E9C8AE07-8447-4228-893A-D3F02F8CBF1DQ33605847-67F44271-1A45-49AB-9990-264D31EB9933Q33759036-CA6C40E5-1F7F-4361-8487-1ECF27C75EADQ33759041-F57F8EE7-6DE2-47B2-813E-F4163BF0D00CQ33898575-B014554E-AE28-4D82-BE50-FB8000C4F33AQ33922065-4B9F8B92-76D1-41DF-8D1C-BBFD3DC09872Q34149975-C99FB32E-52E7-433F-8779-2D78A1CC9B09Q34177472-3B2272FA-0B9F-4A16-9CA8-ADF99A19AA52Q34509609-A8A4B3C5-B528-4A57-A224-39F1F61D80CEQ34772862-7FE720C2-EC59-44DD-A8F1-392E63443B59Q34968407-EE83FF0C-8785-4CBA-8B92-29DC40569AFFQ35043511-11B153D8-1C18-4C03-9D62-85659FD1E7E8Q35169119-42959C7E-E98B-477A-B59E-A5E67467CB06Q35571456-6FF5A643-6451-4266-85B3-5DA0820035B6Q35584827-C45E4077-AD00-4739-9DD3-160061D0BF64Q35590734-D38713EC-E6E2-43B8-8AE7-6A9132DB1D58Q35712615-CB7184DF-1DAC-40E5-B199-9C366B3F7EDAQ35730764-B214EB9A-1C87-4322-BACC-F3016925226DQ36086489-519D02BF-A81E-44BA-8C1E-9F372889B720Q36175374-608D1697-0C80-4010-8964-D90C7F7312E3Q36240246-8A9D446A-22E6-48B3-8698-ADF69863DCB9Q36538990-1D4DF63B-4BB6-4C72-949F-DB5331FC86DFQ36608075-F90EF8EA-81BB-4891-B66D-6FE373BC1FF3Q36882506-8E37D792-C153-4FE3-A318-8B67B262CC57Q37284075-34A069CC-6BF6-43C3-A9CC-7751B216588BQ37418342-FDB05100-A337-477A-9767-CD38FF57C9ABQ37459170-6E684050-F35E-4027-B3D3-3ECACE55AD1EQ37604926-0720040B-A13B-4A86-A16A-48CC911C2A0AQ38066991-ABE18AA7-CA8B-4769-9D17-B102EB3E256DQ38245842-D5D700B2-883C-4C8D-AE15-4217FF234D33Q38840716-6517BF62-74A5-4AF9-876D-A515E73DF560Q38866063-051DCDBF-CAB4-44AC-AA3F-7E68C0E8996EQ47169530-EC79D6B2-7A98-4125-B6B0-3F6C8F7EFA45Q48018805-8F8FBBFC-6840-43A6-92B2-12C50729E48DQ48024114-8145157E-FD4B-4116-826C-DE51BBA1DB33
P2860
Transmission-blocking activities of quinine, primaquine, and artesunate
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Transmission-blocking activities of quinine, primaquine, and artesunate
@ast
Transmission-blocking activities of quinine, primaquine, and artesunate
@en
Transmission-blocking activities of quinine, primaquine, and artesunate
@nl
type
label
Transmission-blocking activities of quinine, primaquine, and artesunate
@ast
Transmission-blocking activities of quinine, primaquine, and artesunate
@en
Transmission-blocking activities of quinine, primaquine, and artesunate
@nl
prefLabel
Transmission-blocking activities of quinine, primaquine, and artesunate
@ast
Transmission-blocking activities of quinine, primaquine, and artesunate
@en
Transmission-blocking activities of quinine, primaquine, and artesunate
@nl
P2860
P50
P3181
P356
P1476
Transmission-blocking activities of quinine, primaquine, and artesunate
@en
P2093
Rachanee Udomsangpetch
Russell E Coleman
P2860
P304
P3181
P356
10.1128/AAC.01472-05
P407
P577
2006-06-01T00:00:00Z